| The projected economic and health burden of uncontrolled asthma in the United States M Yaghoubi, A Adibi, A Safari, JM FitzGerald, M Sadatsafavi American journal of respiratory and critical care medicine 200 (9), 1102-1112, 2019 | 238 | 2019 |
| Statistical and experimental analysis on the behavior of fiber reinforced concretes subjected to drop weight test T Rahmani, B Kiani, M Shekarchi, A Safari Construction and Building Materials 37, 360-369, 2012 | 162 | 2012 |
| The acute COPD exacerbation prediction tool (ACCEPT): a modelling study A Adibi, DD Sin, A Safari, KM Johnson, SD Aaron, JM FitzGerald, ... The Lancet Respiratory Medicine 8 (10), 1013-1021, 2020 | 82 | 2020 |
| Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study W Chen, A Safari, JM FitzGerald, DD Sin, H Tavakoli, M Sadatsafavi Thorax 74 (12), 1113-1119, 2019 | 32 | 2019 |
| Assessing How Health Information Needs of Individuals With Colorectal Cancer Are Met Across the Care Continuum: an International Cross-Sectional Survey H Dau, A Safari, KS El Din, H McTaggart-Cowan, JM Loree, S Gill, ... BMC Cancer, 2020 | 25 | 2020 |
| Longitudinal oral anticoagulant adherence trajectories in patients with atrial fibrillation S Salmasi, MA De Vera, A Safari, LD Lynd, M Koehoorn, AR Barry, ... Journal of the American College of Cardiology 78 (24), 2395-2404, 2021 | 21 | 2021 |
| An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population W Chen, DD Sin, M FitzGerald, A Safari, A Adibi, M Sadatsafavi Chest, 2019 | 20 | 2019 |
| Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD KM Johnson, A Safari, WC Tan, J Bourbeau, JM FitzGerald, M Sadatsafavi, ... International journal of chronic obstructive pulmonary disease, 3983-3995, 2018 | 19 | 2018 |
| Evaluating signs of microangiopathy secondary to diabetes in different areas of the retina with swept source OCTA SG Karst, M Heisler, J Lo, N Schuck, A Safari, MV Sarunic, DAL Maberley, ... Investigative Ophthalmology & Visual Science 61 (5), 8-8, 2020 | 13 | 2020 |
| ACCEPT 2· 0: recalibrating and externally validating the acute COPD exacerbation prediction tool (ACCEPT) A Safari, A Adibi, DD Sin, TY Lee, JK Ho, M Sadatsafavi EClinicalMedicine 51, 2022 | 9 | 2022 |
| Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada B Ng, M Sadatsafavi, A Safari, JM FitzGerald, KM Johnson BMJ open 9 (11), e031306, 2019 | 9 | 2019 |
| Oral anticoagulant adherence and switching in patients with atrial fibrillation: a prospective observational study S Salmasi, A Safari, A Kapanen, A Adelakun, L Kwan, J MacGillivray, ... Research in Social and Administrative Pharmacy 18 (11), 3920-3928, 2022 | 7 | 2022 |
| Generalizability of risk stratification algorithms for exacerbations in COPD JK Ho, A Safari, A Adibi, DD Sin, K Johnson, M Sadatsafavi, N Bansback, ... Chest 163 (4), 790-798, 2023 | 6 | 2023 |
| 16-year trends in asthma hospital admissions in Canada TY Lee, J Petkau, N Mangat, A Safari, JJ Cragg, LD Lynd, JM FitzGerald, ... Annals of Allergy, Asthma & Immunology 129 (4), 475-480. e2, 2022 | 5 | 2022 |
| Display advertising: Estimating conversion probability efficiently A Safari, RMK Altman, TM Loughin arXiv preprint arXiv:1710.08583, 2017 | 5 | 2017 |
| Marginal versus conditional odds ratios when updating risk prediction models M Sadatsafavi, H Tavakoli, A Safari Epidemiology 33 (4), 555-558, 2022 | 4 | 2022 |
| Clinician preferences for neurotechnologies in pediatric drug‐resistant epilepsy: A discrete choice experiment GO Apantaku, PJ McDonald, M Aguiar, LY Cabrera, W Chiong, ... Epilepsia 63 (9), 2338-2349, 2022 | 3 | 2022 |
| Parameter-driven models for time series of count data A Safari, RMK Altman, B Leroux arXiv preprint arXiv:1711.02753, 2017 | 3 | 2017 |
| An overview of reinforcement learning and deep reinforcement learning for condition-based maintenance Z Dehghani Ghobadi, F Haghighi, A Safari International Journal of Reliability, Risk and Safety: Theory and …, 2021 | 2 | 2021 |
| SM1 The Random Effects Warfarin Days' Supply (REWARDS) Model: Development and Validation of a NOVEL Method to Estimate Exposure to Warfarin Using Administrative Data S Salmasi, T Höegg, A Safari, M De Vera, LD Lynd, M Koehoorn, A Barry, ... Value in Health 24, S241, 2021 | 2 | 2021 |
